Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 27 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

4%

1 trials in Phase 3/4

Results Transparency

10%

1 of 10 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

20Total
Not Applicable (17)
Early P 1 (1)
P 2 (1)
P 4 (1)

Trial Status

Completed10
Recruiting6
Active Not Recruiting4
Unknown3
Not Yet Recruiting2
Withdrawn2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 10 completed trials

Clinical Trials (27)

Showing 20 of 20 trials
NCT06124339Not ApplicableActive Not Recruiting

Brain Health Virtual Reality Study

NCT07586410Not ApplicableNot Yet RecruitingPrimary

Study on the Effectiveness and Safety of Two Olive Extract- Based (Olea Europea L. Folium) Supplements, Alone or Combined With a Mullein Extract (Verbascum Thapsus L. Herba Cum Floribus), for the Maintenance of Cognitive Function.

NCT06135740Not ApplicableCompletedPrimary

Impact of Nutrition, Sleep, and Physical Activity on Intellectual Function and Muscle Mass in Older Adults

NCT07335068Not ApplicableActive Not Recruiting

Effects of Exercise Snacking on Physical Fitness, Cognition, and Pain in Institutionalized Older Adults

NCT07377682Recruiting

Real-world Clinical Response to Trazodone in Italy, Poland, and Romania

NCT07338682Phase 2RecruitingPrimary

Evaluation of the Effect of L-Arginine on the Cognitive Function in Geriatric Patients

NCT07170943Not ApplicableWithdrawn

The Effect of Blueberry Supplementation on Cognitive Functioning in Older Adults

NCT06927362Not ApplicableRecruiting

LSVT Big and Dual Task Training in Cognitive Impaired Patients

NCT05481749Recruiting

Neuropsychological Assessment Of The Oldest-Old Population.(NEUROPSIC-GR)

NCT06181513Early Phase 1Recruiting

Probiotics in Mild Alzheimer's Disease

NCT04078178Not ApplicableCompletedPrimary

Crossover Trial for Nicotinamide Riboside in Subjective Cognitive Decline and Mild Cognitive Impairment

NCT03657745Recruiting

Alzheimer's Disease Treatment With Combination of 40Hz Light and Cognitive Therapy

NCT03679026Active Not RecruitingPrimary

The "Motoric Cognitive Risk" Syndrome in the Canadian Population

NCT03633253Active Not RecruitingPrimary

The "Motoric Cognitive Risk" Syndrome in the Quebec Population

NCT06239922Not Yet RecruitingPrimary

Cognitive and Neural Assessment Platform and Localized Norm for Macau Older Adults.

NCT05983913Not ApplicableCompleted

Effects of Wearable Sensor-based Interactive Cognitive-motor Training in Older Adults.

NCT05275257Not ApplicableWithdrawn

Can the Use of Uricap Female Device Lead to Better Care for Women > 75+Years?

NCT05994391Not ApplicableCompleted

A Prospective, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of LasoperinTM on Cognitive Function in Healthy Adults

NCT05401747Not ApplicableUnknownPrimary

A Comprehensive ONline Program for Cognitive Enhancement, Reassurance and Training

NCT05278273Not ApplicableCompletedPrimary

A Feasibility Trial and Protocol for Remote Cognitive Training Developed for Use in a Cognitively Healthy Adult Population During the COVID-19 Pandemic

Scroll to load more

Research Network

Activity Timeline